证券代码：603041 证券简称：美思德 公告编号：2025-007 江苏美思德化学股份有限公司 关于 2024 年年度募集资金存放与实际使用 情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 1 | | | 支付信息披露费用 | B6 | 245,283.02 | | --- | --- | --- | --- | --- | | 本 期 2024 | （ | 项目投入 银行手续费支出 | C1 C2 | 0.00 400.00 | | 年 1-12 月） | | | | | | 累计发生额 | | 利息收入 | C3 | 26,535.05 | | | | 理财收益 | C4 | 0.00 | | 截 至 末 | 期 | 项目投入 | D1=B1+C1 | 416,562,086.50 | | | | 银行手续费支出 | D2=B2+C2 | 5,201.48 | | （2024 12 | 年 | 利息收入 | D3=B3+C3 | 962,465.10 | | 月 31 日）累 | | 理财收益 | D4= ...

江苏美思德化学股份有限公司董事会 关于对会计师事务所 2024 年度履职情况评估报告 江苏美思德化学股份有限公司（以下简称"公司"）分别于2024年04月25 日、2024年05月17日召开公司第四届董事会第十四次会议、2023年年度股东大会， 会议审议批准《关于续聘公司2024年度审计机构的议案》，同意续聘立信会计师 事务所（特殊普通合伙）（以下简称"立信"）为公司2024年度审计机构。 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准 则》《国有企业、上市公司选聘会计师事务所管理办法》等规定和要求，公司对 立信2024年审计过程中的履职情况进行评估。经评估，公司认为立信资质等方面 合规有效，履职保持独立性，勤勉尽责，公允表达意见，具体情况如下： 一、资质条件 立信会计师事务所（特殊普通合伙）（以下简称"立信"）由我国会计泰斗 潘序伦博士于1927年在上海创建，1986年复办，2010年成为全国首家完成改制的 特殊普通合伙制会计师事务所，注册地址为上海市，首席合伙人为朱建弟先生。 立信是国际会计网络BDO的成员所，长期从事证券服务业务，新《证券法》实施 前具有证券、期货业务许可证，具有H ...

证券代码：603041 证券简称：美思德 公告编号：2025-017 江苏美思德化学股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东大会类型和届次 2024年年度股东大会 召开的日期时间：2025 年 5 月 16 日 15 点 00 分 召开地点：南京经济技术开发区恒泰路 8 号汇智科技园 A3 栋之公司七楼会 议室 (五) 网络投票的系统、起止日期和投票时间。 股东大会召开日期：2025年5月16日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (二) 股东大会召集人：董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 (四) 现场会议召开的日期、时间和地点 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 5 月 16 日 至2025 年 5 月 16 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 ...

证券代码：603041 证券简称：美思德 公告编号：2025-004 第五届监事会第四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 江苏美思德化学股份有限公司（以下简称"公司"）第五届监事会第四次会 议（以下简称"本次监事会会议"）通知于 2025 年 04 月 14 日以电子邮件等方 式发出，通知了公司第五届监事会的全体监事和其他列席人员。公司本次监事会 会议于 2025 年 04 月 24 日（星期四）上午在南京经济技术开发区恒泰路 8 号汇 智科技园 A3 栋之公司七楼会议室以现场书面记名投票表决的方式召开。公司本 次监事会会议应到监事 3 人，实到监事 3 人。 公司本次监事会会议由公司监事会主席宋琪女士召集和主持。公司董事会秘 书、财务总监和证券事务代表列席了本次监事会会议。公司本次监事会会议的召 集程序、召开程序以及参与表决的监事人数符合《中华人民共和国公司法》、《公 司章程》、《公司监事会议事规则》等的相关规定。 二、监事会会议审议情况 江苏美思德化学股份有限公司 （一） ...

证券代码：603041 证券简称：美思德 公告编号：2025-003 江苏美思德化学股份有限公司 第五届董事会第五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 江苏美思德化学股份有限公司（以下简称"公司"）第五届董事会第五次会 议（以下简称"本次董事会会议"）通知于 2025 年 04 月 14 日以电子邮件等方 式发出，通知了公司第五届董事会的全体董事和其他列席人员。公司本次董事会 会议于 2025 年 04 月 24 日（星期四）上午在南京经济技术开发区恒泰路 8 号汇 智科技园 A3 栋之公司七楼会议室以现场结合通讯投票表决的方式召开。公司本 次董事会会议应到董事 9 人，实到董事 9 人，其中 5 人现场参会，4 人通讯参会。 公司本次董事会会议由公司董事长孙宇先生召集和主持。公司全体监事和高 级管理人员列席了本次董事会会议。公司本次董事会会议的召集程序、召开程序 以及参与表决的董事人数符合《中华人民共和国公司法》、《公司章程》、《公 司董事会议事规则》等的相关规定。 二、董事 ...

证券代码：603041 证券简称：美思德 公告编号：2025-005 江苏美思德化学股份有限公司 关于公司 2024 年度利润分配预案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例：每股派发现金红利 0.12 元（含税）。 本次以实施权益分派股权登记日登记的总股本扣除公司回购专用证券账 户中股份数量后的股份总数为基数，具体日期将在权益分派实施公告中明确。 在实施权益分派的股权登记日前江苏美思德化学股份有限公司（以下简 称"公司"）应分配股数（总股本扣除公司回购专用证券账户中的股份）发生变 动的，拟维持每股分配比例不变，相应调整分配总额，并将另行公告具体调整情 况。 公司未触及《上海证券交易所股票上市规则（2024 年 4 月修订）》（以下 简称《股票上市规则》）第 9.8.1 条第一款第（八）项规定的可能被实施其他风 险警示的情形。 一、利润分配预案的内容 (一)利润分配方案的具体内容 经立信会计师事务所（特殊普通合伙）审计，母公司 2024 年度实现的净利 润为 6,951.87 万元， ...

Financial Performance - The company's operating revenue for 2024 reached ¥601,170,908.59, representing a year-on-year increase of 19.99% compared to ¥501,006,153.54 in 2023[23]. - The net profit attributable to shareholders decreased by 41.69% to ¥64,142,274.78 in 2024 from ¥109,997,455.73 in 2023[23]. - The basic earnings per share dropped to ¥0.35 in 2024, down 42.62% from ¥0.61 in 2023[24]. - The weighted average return on equity fell to 4.36% in 2024, a decrease of 3.42 percentage points from 7.78% in 2023[24]. - The gross profit margin decreased to 28.92%, down by 9.42 percentage points compared to the previous year[82]. - The total profit amounted to ¥76,640,822.78, a decrease of 40.49% year-on-year[82]. - The company achieved total revenue of ¥601,170,908.59, representing a year-on-year growth of 19.99%[81]. - The main business revenue of ¥583,081,425.74 represented a year-on-year growth of 20.74%[85]. - The main business cost increased to ¥413,651,918.04, reflecting a year-on-year rise of 40.94%[85]. - The company reported a significant decrease in net profit due to high fixed costs and underutilization of capacity in the organic amine catalyst project[24]. Dividend and Share Capital - The company plans to distribute a cash dividend of RMB 1.20 per 10 shares, totaling approximately RMB 21.74 million, which represents 33.89% of the net profit attributable to shareholders for the fiscal year 2024[6]. - The total share capital as of December 31, 2024, is 183,147,692 shares, with 1,999,953 shares held in the repurchase account, resulting in a base of 181,147,739 shares for dividend calculation[6]. - The company does not plan to increase capital reserves or issue bonus shares this year[6]. Audit and Governance - The company has received a standard unqualified audit report from the accounting firm Li Xin[5]. - The company has confirmed that all board members attended the board meeting, ensuring accountability for the report's accuracy[4]. - The company emphasizes strict compliance with corporate governance laws and regulations, ensuring independent operation from its controlling shareholder[186]. - The company held one annual general meeting and one temporary general meeting during the reporting period, with all resolutions passed without any rejections[192]. Research and Development - Research and development expenses increased by 21.21% to ¥35,903,192.51, indicating a focus on innovation[84]. - The company has established multiple innovation platforms and has been involved in 8 national and provincial-level technology projects[74]. - The company has filed for 5 new invention patents and 5 utility model patents in 2024, strengthening its technological foundation for product upgrades and market expansion[3]. - The company emphasizes R&D investment, with established innovation platforms including a provincial technology center and a national postdoctoral research station[67]. - The company is investing $50 million in R&D for new technologies aimed at enhancing product efficiency[197]. Market and Product Development - The company aims to transition from a single agent supplier to a comprehensive solution provider, enhancing its competitive advantage in the polyurethane additives industry[54]. - The company is focusing on green, safe, and environmentally friendly additives, pushing the industry towards green, functional, and high-end transformation[57]. - The company plans to develop differentiated and green additives, targeting markets such as new energy, environmental protection, and electronic information[158]. - The company is actively developing low-odor, reactive catalysts to meet the environmental requirements of the automotive industry, aiming to fill the domestic market gap for high-end soft foam catalysts[6]. - The company has launched a product combination of "foam stabilizers + catalysts," enhancing customer satisfaction and brand reputation through integrated solutions[5]. Risk Management - The company has identified risks related to raw material price fluctuations, exchange rate fluctuations, accounts receivable, safety and environmental protection, and operational environment[9]. - The company faces raw material price fluctuation risks, which could pressure gross margins and profitability if prices rise sharply[169]. - The company holds financial derivatives to mitigate raw material price fluctuation risks, although specific details were not applicable in this report[140]. Sustainability and ESG Initiatives - The company has initiated ESG system construction, integrating green development into its strategic action plan, focusing on process greening and product low-carbonization[44]. - The company has been recognized for its commitment to sustainable development by joining the UN Global Compact, focusing on human rights, labor, environment, and anti-corruption principles[46]. - The company is committed to achieving sustainable development through technological breakthroughs and market deepening strategies[157]. Production Capacity and Operations - The company has established a production capacity of 22,000 tons/year for uniform foam agents and 25,000 tons/year for organic amine catalysts, utilizing DCS automation control systems, achieving international advanced levels in production scale and equipment technology[56]. - The company commenced production of a 25,000 tons/year organic amine catalyst project in October 2023, with full production expected in August 2024[93]. - The production capacity utilization rate for polyurethane foam stabilizers is 91.5%, while the utilization rate for amine catalysts is 19.79%[132]. - The company plans to implement digital control of the entire production process through DCS and MES systems to enhance production efficiency and reduce unit costs[182]. Strategic Partnerships and Market Expansion - The company has established long-term stable partnerships with several well-known domestic and international enterprises, enhancing its brand image and market reputation[56]. - The company is exploring potential acquisitions to enhance its market position, with a budget of $100 million allocated for this purpose[197]. - The company aims to expand into emerging international markets while consolidating its domestic market presence to reduce dependency on a single market[179]. Management and Executive Changes - The company appointed Wang Naifeng as the employee representative supervisor of the fourth supervisory board on January 22, 2024, following the resignation of Zhuang Xinling[199]. - The company completed the election of the fifth independent directors, including Li Jianbo, Tang Wanhong, and Xu Zhijian, during the annual general meetings held on May 17 and July 1, 2024[199]. - Han Dong has been appointed as the new vice president of the company following the restructuring[200]. - Fu Jiahui has been appointed as the new board secretary of the company after the board restructuring[200].

Financial Performance - The company's operating revenue for Q1 2025 was ¥166,692,300.38, representing a 13.49% increase compared to ¥146,878,544.34 in the same period last year[4] - Net profit attributable to shareholders decreased by 60.82% to ¥12,102,063.12 from ¥30,888,899.23 year-on-year[4] - Basic and diluted earnings per share fell by 58.82% to ¥0.07 from ¥0.17 in the same period last year[4] - Net profit for Q1 2025 was ¥10,375,236.43, a decrease of 66.3% from ¥30,829,303.58 in Q1 2024[18] - Basic and diluted earnings per share for Q1 2025 were both ¥0.07, down from ¥0.17 in Q1 2024[18] Cash Flow - The net cash flow from operating activities was negative at -¥25,254,729.79, a decline of 473.90% compared to a positive cash flow of ¥6,754,464.43 in the previous year[4] - Cash flow from operating activities for Q1 2025 was negative at -¥25,254,729.79, compared to positive cash flow of ¥6,754,464.43 in Q1 2024[20] - Cash flow from investing activities generated a net inflow of ¥18,825,552.22 in Q1 2025, contrasting with a net outflow of -¥101,417,741.20 in Q1 2024[21] - Cash and cash equivalents at the end of Q1 2025 totaled ¥198,665,874.22, a decrease from ¥135,436,904.25 at the end of Q1 2024[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,763,818,772.55, down 2.15% from ¥1,802,495,762.25 at the end of the previous year[5] - As of March 31, 2025, the total current assets amounted to ¥977,966,280.40, a decrease from ¥1,007,724,929.91 on December 31, 2024, representing a decline of approximately 2.5%[12] - The company's cash and cash equivalents decreased to ¥229,247,090.84 from ¥278,258,028.62, reflecting a decline of about 17.6%[12] - The total liabilities decreased to ¥266,309,054.85 from ¥315,410,855.08, indicating a reduction of approximately 15.6%[14] - The total assets as of March 31, 2025, were ¥1,763,818,772.55, down from ¥1,802,495,762.25, which is a decrease of about 2.1%[13] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,884[8] - The largest shareholder, Foshan Shunde Demai Chemical Group Co., Ltd., holds 40.88% of the shares, totaling 74,865,000 shares[9] Expenses - Total operating costs for Q1 2025 were ¥156,133,392.47, up 37.0% from ¥113,937,460.50 in Q1 2024[17] - The company reported a significant increase in sales expenses, totaling ¥6,953,170.67 in Q1 2025, compared to ¥6,713,323.86 in Q1 2024[17] - Research and development expenses decreased to ¥7,194,730.01 in Q1 2025 from ¥9,138,658.42 in Q1 2024, indicating a 21.3% reduction[17] - The company experienced a rise in tax expenses, which increased to ¥6,202,091.78 in Q1 2025 from ¥4,768,056.85 in Q1 2024, reflecting a 30.0% increase[18] Equity and Retained Earnings - The company's total equity increased to ¥1,497,509,717.70 from ¥1,487,084,907.17, showing an increase of approximately 0.9%[14] - The retained earnings increased to ¥609,082,376.60 from ¥596,980,313.48, indicating a growth of about 2.0%[14] Operational Challenges - The decline in net profit was primarily due to the underutilization of new project capacity and high fixed cost allocation[7] - The accounts receivable rose to ¥96,888,617.21 from ¥92,682,794.52, marking an increase of about 4.5%[12] - The inventory increased to ¥118,586,932.69 from ¥114,017,808.26, reflecting a growth of approximately 4.2%[12] - The company's long-term investments remained stable at ¥30,000,000.00, unchanged from the previous period[13] - The short-term borrowings increased to ¥41,152,516.35 from ¥35,703,713.82, representing an increase of approximately 15.5%[14]

关于江苏美思德化学股份有限公司 2024 年度募集资金存放与使用情况专项报告的 鉴证报告 信会师报字[2025]第 ZH10112 号 江苏美思德化学股份有限公司全体股东: 我们接受委托,对后附的江苏美思德化学股份有限公司(以下简 称"美思德股份") 2024年度募集资金存放与使用情况专项报告(以 下简称"募集资金专项报告"）执行了合理保证的鉴证业务。 一、董事会的责任 美思德股份董事会的责任是按照中国证券监督管理委员会《上市 公司监管指引第2号 -- 上市公司募集资金管理和使用的监管要求 (2022年修订)》(证监会公告〔2022〕15号)、《上海证券交易所 上市公司自律监管指引第1号 -- 规范运作》以及《上海证券交易所 上市公司自律监管指南第1号 -- 公告格式》的相关规定编制募集资 金专项报告。这种责任包括设计、执行和维护与募集资金专项报告编 制相关的内部控制,确保募集资金专项报告真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏。 二、注册会计师的责任 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）"进行查验 关于江苏美思德化学股份有限公 ...

江苏美思德化学股份有限公司 内部控制审计报告 信会师报字[2025]第 ZH10110 号 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mlcf.gov.cn）"进行查报 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc 报告编码：沪25576X65FU 立信会计师事务所(特殊普通合伙) HINA SHU LUN PAN CERTIFIED PUBLIC ACCOUNTAN 内部控制审计报告 信会师报字[2025]第 ZH10110 号 江苏美思德化学股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相 关要求,我们审计了江苏美思德化学股份有限公司(以下简称美思德 股份)2024年12月31 目的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企 业内部控制评价指引》的规定,建立健全和有效实施内部控制,并评 价其有效性是美思德股份董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的 有效性发表审计意见,并对注意到 ...